To cite this paper use one of the standards below:
The human Respiratory Syncytial Virus (hRSV) is one of the main causes of acute respiratory diseases such as bronchiolitis and pneumonia in newborns, children, and elderly. So far, there is no effective vaccine against hRSV and the only commonly offered licensed treatment, a monoclonal antibody directed to viral fusion protein, is a costly drug that has had adverse reactions. The hRSV M2-1 protein is an important transcriptional anti-termination factor of the viral polymerase complex. The role of M2-1 in the context of this complex is determined by the interaction of its globular domain (dgM2-1) with viral messenger RNA and phosphoprotein. This scenario of intermolecular interactions makes dgM2-1 a potential target for the development of inhibitors of the viral replication cycle. In this sense, this study aimed to identify ligands (molecular fragments) with the potential to inhibit the interaction site of dgM2-1 with RNA and phosphoprotein. For that, the systematic approach of NMR-based fragment screening was used, selecting the most promising fragments from the DSI-PL Enamine library based on measurements of chemical shift perturbation (CSP), transverse relaxation time (T2), and WaterLOGSY. The five fragments identified as a hit had at least two positive parameters used for the screening. From this set of ligands presenting promising interaction with dgM2-1, four of them showed CSP greater than 3 Hz while two of them were greater than 6 Hz. All hits showed positive results for the T2 experiments but only two had positive cases for WaterLOGSY. Further analyses are required to characterize the binding site of these ligands, residues involved in the interaction and dissociation constants, and the development of this research contributes to the design of an alternative strategy to combat infections caused by hRSV targeting dgM2-1 since its results provide relevant molecular information for potential drugs with antiviral action against this virus.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper